pI: 6.9622 |
Length (AA): 464 |
MW (Da): 51026 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 413 | 5eqj (A) | 1 | 451 | 21.00 | 0 | 1 | 0.766686 | 1.28 |
7 | 411 | 5ccb (B) | 20 | 460 | 28.00 | 0 | 1 | 1.08544 | 0.42 |
173 | 264 | 4l7v (A) | 30 | 137 | 11.00 | 0.97 | 0.02 | 0.281876 | -0.17 |
407 | 461 | 5hmo (A) | 804 | 864 | 11.00 | 0.88 | 0 | 0.180134 | -0.57 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128776)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G45730 | eukaryotic initiation factor 3 gamma subunit family protein |
Babesia bovis | BBOV_IV009810 | initiation factor 3 gamma subunit containing protein |
Brugia malayi | Bm1_28855 | Eukaryotic initiation factor 3, gamma subunit family protein |
Candida albicans | CaO19.500 | similar to S. cerevisiae GCD10 (YNL062C) tRNA(1-methyladenosine) methyltransferase subunit, translational repressor of GCN4 |
Candida albicans | CaO19.8130 | similar to S. cerevisiae GCD10 (YNL062C) tRNA(1-methyladenosine) methyltransferase subunit, translational repressor of GCN4 |
Caenorhabditis elegans | CELE_ZK858.7 | Protein ZK858.7 |
Dictyostelium discoideum | DDB_G0281175 | tRNA (adenine-N(1)-)-methyltransferase non-catalytic subunit |
Drosophila melanogaster | Dmel_CG9596 | CG9596 gene product from transcript CG9596-RC |
Echinococcus granulosus | EgrG_000106300 | tRNA adenine N1 methyltransferase |
Entamoeba histolytica | EHI_085970 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000106300 | tRNA (adenine N(1)) methyltransferase |
Homo sapiens | ENSG00000089195 | tRNA methyltransferase 6 |
Leishmania braziliensis | LbrM.35.6060 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_366030.1 | Gcd10p family, putative |
Leishmania infantum | LinJ.36.6030 | hypothetical protein, conserved |
Leishmania major | LmjF.36.5780 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.5780 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09077 | eukaryotic initiation factor 3 |
Mus musculus | ENSMUSG00000037376 | tRNA methyltransferase 6 |
Neospora caninum | NCLIV_023490 | hypothetical protein, conserved |
Oryza sativa | 4334938 | Os04g0112300 |
Onchocerca volvulus | OVOC8152 |
|
Saccharomyces cerevisiae | YNL062C | Gcd10p |
Schistosoma japonicum | Sjp_0210460 | ko:K03256 translation initiation factor eIF-3 subunit P62, putative |
Schistosoma japonicum | Sjp_0317490 | IPR007316,Eukaryotic initiation factor 3, gamma subunit,domain-containing |
Schistosoma mansoni | Smp_012860 | translation initiation factor eif3-related |
Schmidtea mediterranea | mk4.002395.08 | tRNA |
Trypanosoma brucei gambiense | Tbg972.10.11040 | hypothetical protein, conserved |
Trypanosoma brucei | Tb11.v5.0508 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.9020 | Gcd10p family, putative |
Trypanosoma congolense | TcIL3000_10_7800 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.504171.30 | Gcd10p family, putative |
Trypanosoma cruzi | TcCLB.509795.30 | Gcd10p family, putative |
Toxoplasma gondii | TGME49_281545 | eukaryotic initiation factor 3, gamma subunit protein |
Theileria parva | TP01_0787 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9020 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9020 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9020 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.9020 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_ZK858.7 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_ZK858.7 | Caenorhabditis elegans | slow growth | wormbase |
YNL062C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_281545 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.